Arpelos Biosciences

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.arpelos.com/

Last Round

Seed

Mar 15, 2024

Total Funding Raised

$9.6M

Company Overview

Arpelos Biosciences is a biotechnology company that develops multivalent medicines to achieve unprecedented potency and selectivity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

multivalent medicinesmultispecific biologicstargeted therapeuticsprotein engineeringdrug discoverybiopharmacomputational drug discoveryimmunologybiologicsprecision medicinetherapeutics developmentpre-clinical therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arpelos Biosciences Comps

Public and private peers based on sector, stage, and business model.

Arpelos Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arpelos Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Mar 15, 2024

View all Funding Rounds

Arpelos Biosciences Investors

Notable investors and investment history

Arpelos Biosciences investors
Investor	Rounds
Lux Capital	Seed
General Catalyst	Seed
Pillar VC	Seed
82VS	Seed
Wing Venture Capital	Seed
8VC	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 15, 2024
$9.6M raised from General Catalyst and 8VC.

View all signals

Arpelos Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Arpelos Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arpelos Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Year Founded2024

Last FundingMar 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.